Volitionrx Return on Equity (ROE) Growth & History (VNRX)

Volitionrx's return on equity was −404.02% for fiscal 2022.

View full Volitionrx company overview

Volitionrx annual return on equity history

Volitionrx annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20222022-12-31−404.02%−245.33 pp
20212021-12-31−158.69%−24.89 pp
20202020-12-31−133.80%−11.55 pp
20192019-12-31−122.24%+40.74 pp
20182018-12-31−162.99%−68.11 pp
20172017-12-31−94.88%−7.40 pp
20162016-12-31−87.48%+209.76 pp
20152015-12-31−297.24%+1268.95 pp
20142014-12-31−1,566.19%−1076.21 pp
20132013-12-31−489.98%−65.27 pp
20122012-12-31−424.71%

Volitionrx return on equity trends

Over the last five fiscal years, Volitionrx's return on equity decreased from −94.88% to −404.02%, a change of −309.14 percentage points. The latest reported quarter, Q3 2023, shows −444.79%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Volitionrx source filings ↗

Community posts

It’s quiet here.

No posts about VNRX yet. Start the conversation.

Write the first post